<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01608516</url>
  </required_header>
  <id_info>
    <org_study_id>80/10</org_study_id>
    <nct_id>NCT01608516</nct_id>
  </id_info>
  <brief_title>Multimodal Imaging Assessment of the Inflammatory Atheromatous Plaque</brief_title>
  <official_title>Multimodal Assessment of the Inflammatory Atheromatous Plaque : Comparison Between 68Ga-NODAGA-RGD PET/CT, 18F-FDG PET/CT, MRI AND US</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Lausanne Hospitals</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swiss Heart Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Lausanne Hospitals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study aims at assessing the ability of 68Ga-NODAGA-RGD PET/CT for the detection
      of inflammatory atheromatous plaques in the carotid arteries, compared to 18F-FDG PET/CT, MRI
      and US and to determine the contribution of each imaging technique. Current gold standard for
      inflammation is histopathology.

      Hypothesis : 68Ga-NODAGA-RGD might give a better initial evaluation of patients with
      atheromatous plaques in the carotid artery eligible for endarterectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with indication for endarterectomy will be presented the present protocol. If
      inclusion criteria are fulfilled, patients will have a 18F-FDG PET/CT + carotid US performed
      6 to 2 days before endarterectomy and 68Ga-NODAGA-RGD PET/CT + MRI performed the day before
      endarterectomy. Histopathological sample will be analyzed to measure plaque inflammation.

      All imaging results and histopathology results will be pooled and compared.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of each method of imaging for the detection of inflammatory atheromatous plaques</measure>
    <time_frame>Within1 month of endarterectomy</time_frame>
    <description>The potential of each of the methods of imaging for the detection of inflammatory atheromatous plaques will be compared. For that purpose, the capacity of every criterion of primary assessment to determine the presence of an unstable plaque will be studied compared with the histopathological sample.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of AUC of the imaging methods</measure>
    <time_frame>Within1 month of endarterectomy</time_frame>
    <description>A comparison of the AUC will be realized to determine the superiority of a method compared with the other one, by a non parametric test comparing AUC , ROC curves respectively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of histopathological sample of endarterectomy</measure>
    <time_frame>Within1 month of endarterectomy</time_frame>
    <description>The histopathological analysis will be the degree of local inflammation estimated by the macrophagic infiltration as well as the degree of neovascularization.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Inflammation</condition>
  <condition>Atheromatous Plaques</condition>
  <condition>Carotid Artery Diseases</condition>
  <arm_group>
    <arm_group_label>68Ga-NODAGA-RGD radiotracer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients will undergo a 68Ga-NODAGA-RGD PET/CT, a 18F-FDG PET/CT, a MRI and a US.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>68Ga-NODAGA-RGD PET/CT</intervention_name>
    <description>200 MBq 68 Ga-NODAGA-RGD will be administered i.v. and images centred on the carotid area acquired</description>
    <arm_group_label>68Ga-NODAGA-RGD radiotracer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &lt;= 85 years

          -  Karnofsky &gt;= 80%

          -  patient with indication ofr carotid endarterectomy

          -  signed consent form

        Exclusion Criteria:

          -  indication for surgery other than endarterectomy &lt;14 days

          -  contraindication to surgery

          -  contraindication to MRI

          -  contraindication to gadolinium injection (stage 4/5 kidney insufficiency,
             GFR&lt;30ml/min/1.73m2)

          -  pregnancy, breastfeeding

          -  lack of discernment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John O. Prior, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lausanne University Hospitals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>John O. Prior, PhD, MD</last_name>
    <phone>+41 21 314 43 48</phone>
    <email>john.prior@chuv.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Emmanuel Deshayes, MD</last_name>
    <phone>+41 21 314 02 20</phone>
    <email>emmanuel.deshayes@chuv.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Vaudois</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 16, 2012</study_first_submitted>
  <study_first_submitted_qc>May 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 31, 2012</study_first_posted>
  <last_update_submitted>November 13, 2016</last_update_submitted>
  <last_update_submitted_qc>November 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Lausanne Hospitals</investigator_affiliation>
    <investigator_full_name>John O. Prior</investigator_full_name>
    <investigator_title>Chief of Department of Nuclear Medicine</investigator_title>
  </responsible_party>
  <keyword>PET/CT</keyword>
  <keyword>68Ga-NODAGA-RGD</keyword>
  <keyword>18F-FDG</keyword>
  <keyword>MRI</keyword>
  <keyword>US ultrasound</keyword>
  <keyword>inflammatory atheromatous plaque</keyword>
  <keyword>endarterectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Carotid Artery Diseases</mesh_term>
    <mesh_term>Plaque, Atherosclerotic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluorodeoxyglucose F18</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

